This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

April 5-8, 2021
Delivered in a 100% Virtual Format

David Ausländer, PhD
Principal Scientist, Cell Line Development at Novartis Pharma AG


David Ausländer joined Novartis in 2017 as Principal Scientist of Cell Line Development. Before, he worked as research scientist at ETH Zürich with the focus on technology development for mammalian cell engineering and Synthetic Biology. He received his doctorate from ETH Zürich in 2014, where he developed synthetic gene circuits for mammalian cells with applications in biopharmaceutical manufacturing and cell-based therapies.

Agenda Sessions

  • Generation of Improved Host Cell Lines for Biomanufacturing using Vector & Cell Line Engineering Technologies


Speakers at this event